Interpace Biosciences, Inc is a diagnostics & research business based in the US. Interpace Biosciences shares (IDXG) are listed on the OTCQX (a marketplace for buying and selling "over the counter" stocks which aren't listed on a formal stock exchange) and all prices are listed in US Dollars. Interpace Biosciences employs 152 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Interpace Biosciences
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – IDXG – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Interpace Biosciences stock price (OTCQX: IDXG)Use our graph to track the performance of IDXG stocks over time.
Interpace Biosciences shares at a glance
|Latest market close||$8.87|
|52-week range||$2.57 - $10.51|
|50-day moving average||$9.91|
|200-day moving average||$7.00|
|Wall St. target price||$9.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.49|
Buy Interpace Biosciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Interpace Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Interpace Biosciences price performance over time
|1 week (2021-07-19)||N/A|
|1 month (2021-06-30)||-13.76%|
|3 months (2021-04-30)||2.24%|
|6 months (2021-01-26)||N/A|
|1 year (2020-07-26)||N/A|
|2 years (2019-07-26)||N/A|
|3 years (2018-07-26)||N/A|
|5 years (2016-07-26)||N/A|
Interpace Biosciences financials
|Revenue TTM||$33.2 million|
|Gross profit TTM||$10.7 million|
|Return on assets TTM||-23.31%|
|Return on equity TTM||-71.4%|
|Market capitalisation||$35.4 million|
TTM: trailing 12 months
Shorting Interpace Biosciences shares
There are currently 47,355 Interpace Biosciences shares held short by investors – that's known as Interpace Biosciences's "short interest". This figure is 58.9% up from 29,806 last month.
There are a few different ways that this level of interest in shorting Interpace Biosciences shares can be evaluated.
Interpace Biosciences's "short interest ratio" (SIR)
Interpace Biosciences's "short interest ratio" (SIR) is the quantity of Interpace Biosciences shares currently shorted divided by the average quantity of Interpace Biosciences shares traded daily (recently around 249236.84210526). Interpace Biosciences's SIR currently stands at 0.19. In other words for every 100,000 Interpace Biosciences shares traded daily on the market, roughly 190 shares are currently held short.
However Interpace Biosciences's short interest can also be evaluated against the total number of Interpace Biosciences shares, or, against the total number of tradable Interpace Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Interpace Biosciences's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Interpace Biosciences shares in existence, roughly 10 shares are currently held short) or 0.0138% of the tradable shares (for every 100,000 tradable Interpace Biosciences shares, roughly 14 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Interpace Biosciences.
Find out more about how you can short Interpace Biosciences stock.
Interpace Biosciences share dividends
We're not expecting Interpace Biosciences to pay a dividend over the next 12 months.
Have Interpace Biosciences's shares ever split?
Interpace Biosciences's shares were split on a 1:10 basis on 14 January 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Interpace Biosciences shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Interpace Biosciences shares which in turn could have impacted Interpace Biosciences's share price.
Interpace Biosciences share price volatility
Over the last 12 months, Interpace Biosciences's shares have ranged in value from as little as $2.5721 up to $10.51. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (OTCQX average) beta is 1, while Interpace Biosciences's is 1.2644. This would suggest that Interpace Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Interpace Biosciences overview
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc.
Stocks similar to Interpace Biosciences
Interpace Biosciences in the news
Interpace Biosciences, Inc. (IDXG) Is a Great Choice for "Trend" Investors, Here's Why
Frequently asked questionsWhat percentage of Interpace Biosciences is owned by insiders or institutions?
Currently 25.511% of Interpace Biosciences shares are held by insiders and 0.319% by institutions. How many people work for Interpace Biosciences?
Latest data suggests 152 work at Interpace Biosciences. When does the fiscal year end for Interpace Biosciences?
Interpace Biosciences's fiscal year ends in December. Where is Interpace Biosciences based?
Interpace Biosciences's address is: Morris Corporate Center 1, Parsippany, NJ, United States, 07054 What is Interpace Biosciences's ISIN number?
Interpace Biosciences's international securities identification number is: US46062X3035 What is Interpace Biosciences's CUSIP number?
Interpace Biosciences's Committee on Uniform Securities Identification Procedures number is: 46062X105
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert